Trial Profile
A randomised, double-blind, placebo controlled trial of the effect versus placebo of twice daily doses of mannitol (80mg) for one week on nasal mucociliary clearance in healthy adults and adults with allergic rhinitis or chronic sinusitis.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 23 Jan 2024
Price :
$35
*
At a glance
- Drugs Mannitol (Primary) ; Mannitol (Primary)
- Indications Allergic rhinitis; Chronic sinusitis
- Focus Therapeutic Use
- Acronyms MCC123
- 04 Dec 2023 According to a Syntara Limited media release, Pharmaxis has changed its name to Syntara Limited
- 10 Dec 2018 Status changed from recruiting to completed.
- 15 May 2009 New trial record